Profound Medical PROF Ratios & Valuation
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| Profitability | ||||
| Gross margin | 70.8%+4.9pp | 65.9%+6.0pp | 59.9%— | |
| Operating margin | -256.3%+53.3pp | -309.6%+88.4pp | -398%— | |
| Net margin | -264.4%-4.0pp | -260.4%+133pp | -393.4%— | |
| EBITDA margin | -252.8%+48.0pp | -300.8%+84.3pp | -385.1%— | |
| Free cash flow margin | -238.4%— | —— | —— | |
| Returns | ||||
| Return on equity | -67.1%-6.4pp | -60.7%+6.9pp | -67.6%— | |
| Return on assets | -57.6%-8.9pp | -48.7%— | —— | |
| Return on invested capital | -374.1%-92.8pp | -281.3%— | —— | |
| Efficiency | ||||
| Asset turnover | 0.2×0.0× | 0.2×— | —— | |
| Inventory turnover | 0.7×+0.1× | 0.6×— | —— | |
| Liquidity | ||||
| Current ratio | 12.5×+2.0× | 10.5×+3.9× | 6.6×— | |
| Quick ratio | 11.2×+1.5× | 9.6×+4.2× | 5.5×— | |
| Cash ratio | 9.8×+1.5× | 8.4×+4.2× | 4.1×— | |
| Leverage | ||||
| Debt-to-equity | 0.1×0.0× | 0.1×-0.2× | 0.3×— | |
| Debt-to-assets | 0.1×0.0× | 0.1×-0.1× | 0.2×— | |
| Interest coverage | -38.6×-15.5× | -23×+13.9× | -37×— | |
| Per Share | ||||
| Book value per share | $2.20-9.9% | $2.44+65.5% | $1.47— | |
| Valuation | ||||
| Market capitalization | $241.65M+30.7% | $225.51M+24.3% | $181.4M-20.2% | |
| Enterprise value | $198.81M+28.7% | $175.72M+7.8% | $163.05M— | |
| Price / sales | 12.8×-2.8× | 21.1×-4.1× | 25.2×— | |
| Price / book | 4.1×-0.6× | 3.7×-2.1× | 5.8×+1.5× | |
| EV / sales | 10.6×-2.5× | 16.5×-6.2× | 22.6×— | |
| Free cash flow yield | -13.8%— | —— | —— | |
| Earnings yield | -16.1%+5.9pp | -12.3%+3.3pp | -15.6%— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Profound Medical's profit margins?
- Profound Medical (PROF) runs a 71.1% gross margin and a -202.6% operating margin, with a -206.8% net margin.
- Where do Profound Medical's ratios come from?
- Every ratio is computed from Profound Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
